Science 28 May 1993: Vol. 260. no. 5112, pp. 1335 - 1338 DOI: 10.1126/science.8388126

Prev | Table of Contents | Next

Articles

Disruption of TGF-{beta} Signaling Prevents the Generation of Tumor-Sensitized Regulatory T Cells and Facilitates Therapeutic Antitumor Immunity.

U. Petrausch, S. M. Jensen, C. Twitty, C. H. Poehlein, D. P. Haley, E. B. Walker, and B. A. Fox (2009)
J. Immunol. 183, 3682-3689
 |  Abstract »  |  Full Text »  |  PDF »

Cancer-Associated Transforming Growth Factor {beta} Type II Receptor Gene Mutant Causes Activation of Bone Morphogenic Protein-Smads and Invasive Phenotype.

S. Bharathy, W. Xie, J. M. Yingling, and M. Reiss (2008)
Cancer Res. 68, 1656-1666
 |  Abstract »  |  Full Text »  |  PDF »

Transforming growth factor-{beta} signaling and ubiquitinators in cancer.

E. Glasgow and L. Mishra (2008)
Endocr. Relat. Cancer 15, 59-72
 |  Abstract »  |  Full Text »  |  PDF »

Cripto Is a Noncompetitive Activin Antagonist That Forms Analogous Signaling Complexes with Activin and Nodal.

J. A. Kelber, G. Shani, E. C. Booker, W. W. Vale, and P. C. Gray (2008)
J. Biol. Chem. 283, 4490-4500
 |  Abstract »  |  Full Text »  |  PDF »

Clinical features in a family with an R460H mutation in transforming growth factor {beta} receptor 2 gene.

C Law, D Bunyan, B Castle, L Day, I Simpson, G Westwood, and B Keeton (2006)
J. Med. Genet. 43, 908-916
 |  Abstract »  |  Full Text »  |  PDF »

Smad4-dependent Regulation of Urokinase Plasminogen Activator Secretion and RNA Stability Associated with Invasiveness by Autocrine and Paracrine Transforming Growth Factor-beta.

S.-R. Shiou, P. K. Datta, P. Dhawan, B. K. Law, J. M. Yingling, D. A. Dixon, and R. D. Beauchamp (2006)
J. Biol. Chem. 281, 33971-33981
 |  Abstract »  |  Full Text »  |  PDF »

Signaling cross-talk between IGF-binding protein-3 and transforming growth factor-{beta} in mesenchymal chondroprogenitor cell growth.

L O'Rear, L Longobardi, M Torello, B K Law, H L Moses, F Chiarelli, and A Spagnoli (2005)
J. Mol. Endocrinol. 34, 723-737
 |  Abstract »  |  Full Text »  |  PDF »

THE ROLE OF TGF-{beta} IN EPITHELIAL MALIGNANCY AND ITS RELEVANCE TO THE PATHOGENESIS OF ORAL CANCER (PART II).

S.S. Prime, M. Davies, M. Pring, and I.C. Paterson (2004)
Critical Reviews in Oral Biology & Medicine 15, 337-347
 |  Abstract »  |  Full Text »  |  PDF »

Concomitant Overexpression of Cyclooxygenase-2 in HER-2-Positive on Smad4-Reduced Human Gastric Carcinomas Is Associated with a Poor Patient Outcome.

H. Okano, H. Shinohara, A. Miyamoto, K. Takaori, and N. Tanigawa (2004)
Clin. Cancer Res. 10, 6938-6945
 |  Abstract »  |  Full Text »  |  PDF »

Targeting Endogenous Transforming Growth Factor {beta} Receptor Signaling in SMAD4-Deficient Human Pancreatic Carcinoma Cells Inhibits Their Invasive Phenotype1.

G. Subramanian, R. E. Schwarz, L. Higgins, G. McEnroe, S. Chakravarty, S. Dugar, and M. Reiss (2004)
Cancer Res. 64, 5200-5211
 |  Abstract »  |  Full Text »  |  PDF »

Transforming Growth Factor {beta}/Smad3 Signaling Regulates IRF-7 Function and Transcriptional Activation of the Beta Interferon Promoter.

J. Qing, C. Liu, L. Choy, R.-Y. Wu, J. S. Pagano, and R. Derynck (2004)
Mol. Cell. Biol. 24, 1411-1425
 |  Abstract »  |  Full Text »  |  PDF »

CLAVATA1 Dominant-Negative Alleles Reveal Functional Overlap between Multiple Receptor Kinases That Regulate Meristem and Organ Development.

A. Dievart, M. Dalal, F. E. Tax, A. D. Lacey, A. Huttly, J. Li, and S. E. Clark (2003)
PLANT CELL 15, 1198-1211
 |  Abstract »  |  Full Text »

Smads 2 and 3 Are Differentially Activated by Transforming Growth Factor-beta (TGF-beta ) in Quiescent and Activated Hepatic Stellate Cells. CONSTITUTIVE NUCLEAR LOCALIZATION OF Smads IN ACTIVATED CELLS IS TGF-beta -INDEPENDENT.

C. Liu, M. D. A. Gaca, E. S. Swenson, V. F. Vellucci, M. Reiss, and R. G. Wells (2003)
J. Biol. Chem. 278, 11721-11728
 |  Abstract »  |  Full Text »  |  PDF »

Reconstitution of Lethally Irradiated Adult Mice with Dominant Negative TGF-{beta} Type II Receptor-Transduced Bone Marrow Leads to Myeloid Expansion and Inflammatory Disease.

A. H. Shah, W. B. Tabayoyong, S. Y. Kimm, S.-J. Kim, L. van Parijs, and C. Lee (2002)
J. Immunol. 169, 3485-3491
 |  Abstract »  |  Full Text »  |  PDF »

Metapopulation dynamics and spatial heterogeneity in cancer.

I. Gonzalez-Garcia, R. V. Sole, and J. Costa (2002)
PNAS 99, 13085-13089
 |  Abstract »  |  Full Text »  |  PDF »

Regulation of TGF-beta ligand and receptor expression in neonatal rat lungs exposed to chronic hypoxia.

A. G. Vicencio, O. Eickelberg, M. C. Stankewich, M. Kashgarian, and G. G. Haddad (2002)
J Appl Physiol 93, 1123-1130
 |  Abstract »  |  Full Text »  |  PDF »

When cell biology meets development: endocytic regulation of signaling pathways.

E. S. Seto, H. J. Bellen, and T. E. Lloyd (2002)
Genes & Dev. 16, 1314-1336
 |  Full Text »  |  PDF »

Disruption of Transforming Growth Factor {beta} Signaling by a Novel Ligand-dependent Mechanism.

T. Fernandez, S. Amoroso, S. Sharpe, G. M. Jones, V. Bliskovski, A. Kovalchuk, L. M. Wakefield, S.-J. Kim, M. Potter, and J. J. Letterio (2002)
J. Exp. Med. 195, 1247-1255
 |  Abstract »  |  Full Text »  |  PDF »

Transient Disruption of Autocrine TGF-{beta} Signaling Leads to Enhanced Survival and Proliferation Potential in Single Primitive Human Hemopoietic Progenitor Cells.

X. Fan, G. Valdimarsdottir, J. Larsson, A. Brun, M. Magnusson, S. E. Jacobsen, P. ten Dijke, and S. Karlsson (2002)
J. Immunol. 168, 755-762
 |  Abstract »  |  Full Text »  |  PDF »

Integrin beta 1 Signaling Is Necessary for Transforming Growth Factor-beta Activation of p38MAPK and Epithelial Plasticity.

N. A. Bhowmick, R. Zent, M. Ghiassi, M. McDonnell, and H. L. Moses (2001)
J. Biol. Chem. 276, 46707-46713
 |  Abstract »  |  Full Text »  |  PDF »

Inducible Expression of Transforming Growth Factor {beta}1 in Papillomas Causes Rapid Metastasis.

B. H. Weeks, W. He, K. L. Olson, and X.-J. Wang (2001)
Cancer Res. 61, 7435-7443
 |  Abstract »  |  Full Text »  |  PDF »

Soluble Type II Transforming Growth Factor-{beta} (TGF-{beta}) Receptor Inhibits TGF-{beta} Signaling in COLO-357 Pancreatic Cancer Cells in Vitro and Attenuates Tumor Formation.

M. A. Rowland-Goldsmith, H. Maruyama, T. Kusama, S. Ralli, and M. Korc (2001)
Clin. Cancer Res. 7, 2931-2940
 |  Abstract »  |  Full Text »  |  PDF »

Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta.

J. Zavadil, M. Bitzer, D. Liang, Y.-C. Yang, A. Massimi, S. Kneitz, E. Piek, and E. P. Bottinger (2001)
PNAS 98, 6686-6691
 |  Abstract »  |  Full Text »  |  PDF »

Stimulation of pro-{alpha}1(I) collagen by TGF-{beta}1 in mesangial cells: role of the p38 MAPK pathway.

B. Y. Chin, A. Mohsenin, S. X. Li, A. M. K. Choi, and M. E. Choi (2001)
Am J Physiol Renal Physiol 280, F495-F504
 |  Abstract »  |  Full Text »  |  PDF »

Fibrogenesis: V. TGF-beta signaling pathways.

R. G. Wells (2000)
Am J Physiol Gastrointest Liver Physiol 279, G845-G850
 |  Abstract »  |  Full Text »  |  PDF »

Role of Transforming Growth Factor-{beta} Signaling in Cancer.

M. P. de Caestecker, E. Piek, and A. B. Roberts (2000)
J Natl Cancer Inst 92, 1388-1402
 |  Abstract »  |  Full Text »  |  PDF »

Ontogeny and localization of TGF-beta type I receptor expression during lung development.

Y. Zhao, S. L. Young, J. C. McIntosh, M. P. Steele, and R. Silbajoris (2000)
Am J Physiol Lung Cell Mol Physiol 278, L1231-L1239
 |  Abstract »  |  Full Text »  |  PDF »

Roles of Autocrine TGF-{beta} Receptor and Smad Signaling in Adipocyte Differentiation.

L. Choy, J. Skillington, and R. Derynck (2000)
J. Cell Biol. 149, 667-682
 |  Abstract »  |  Full Text »  |  PDF »

Disruption of T Cell Homeostasis in Mice Expressing a T Cell-Specific Dominant Negative Transforming Growth Factor {beta} II Receptor.

P. J. Lucas, S.-J. Kim, S. J. Melby, and R. E. Gress (2000)
J. Exp. Med. 191, 1187-1196
 |  Abstract »  |  Full Text »  |  PDF »

Selective Loss of the Transforming Growth Factor-{beta} Apoptotic Signaling Pathway in Mutant NRP-154 Rat Prostatic Epithelial Cells.

S. Larisch-Bloch, D. Danielpour, N. S. Roche, R. Lotan, A. Y. Hsing, H. Kerner, T. Hajouj, R. J. Lechleider, and A. B. Roberts (2000)
Cell Growth Differ. 11, 1-10
 |  Abstract »  |  Full Text »

Transforming Growth Factor-beta -mediated p15INK4B Induction and Growth Inhibition in Astrocytes Is SMAD3-dependent and a Pathway Prominently Altered in Human Glioma Cell Lines.

J. N. Rich, M. Zhang, M. B. Datto, D. D. Bigner, and X.-F. Wang (1999)
J. Biol. Chem. 274, 35053-35058
 |  Abstract »  |  Full Text »  |  PDF »

Loss of Responsiveness to Transforming Growth Factor {beta} Induces Malignant Transformation of Nontumorigenic Rat Prostate Epithelial Cells.

B. Tang, K. de Castro, H. E. Barnes, W. T. Parks, L. Stewart, E. P. Bottinger, D. Danielpour, and L. M. Wakefield (1999)
Cancer Res. 59, 4834-4842
 |  Abstract »  |  Full Text »  |  PDF »

Blocking Transforming Growth Factor {beta} Signaling in Transgenic Epidermis Accelerates Chemical Carcinogenesis: A Mechanism Associated with Increased Angiogenesis.

C. Go, P. Li, and X.-J. Wang (1999)
Cancer Res. 59, 2861-2868
 |  Abstract »  |  Full Text »  |  PDF »

Evidence for Control of Nitric Oxide Synthesis by Intracellular Transforming Growth Factor-ß1 in Tumor Cells : Implications for Tumor Development.

P. Lagadec, S. Raynal, B. Lieubeau, N. Onier, L. Arnould, V. Saint-Giorgio, D. A. Lawrence, and J.-F. Jeannin (1999)
Am. J. Pathol. 154, 1867-1876
 |  Abstract »  |  Full Text »  |  PDF »

Role of Elevated Plasma Transforming Growth Factor-ß1 Levels in Wound Healing.

M. Shah, D. Revis, S. Herrick, R. Baillie, S. Thorgeirson, M. Ferguson, and A. Roberts (1999)
Am. J. Pathol. 154, 1115-1124
 |  Abstract »  |  Full Text »  |  PDF »

Coordinate regulation of cyclooxygenase-2 and TGF-ß1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors.

J. Shao, H. Sheng, R. Aramandla, M. A. Pereira, R. A. Lubet, E. Hawk, L. Grogan, I. R. Kirsch, M. K. Washington, R. D. Beauchamp, et al. (1999)
Carcinogenesis 20, 185-191
 |  Abstract »  |  Full Text »  |  PDF »

Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass.

E Filvaroff, A Erlebacher, J Ye, S. Gitelman, J Lotz, M Heillman, and R Derynck (1999)
Development 126, 4267-4279
 |  Abstract »  |  PDF »

Heteromeric and Homomeric Transforming Growth Factor-beta Receptors Show Distinct Signaling and Endocytic Responses in Epithelial Cells.

J. J. E. Dore Jr., M. Edens, N. Garamszegi, and E. B. Leof (1998)
J. Biol. Chem. 273, 31770-31777
 |  Abstract »  |  Full Text »  |  PDF »

The Type II Transforming Growth Factor (TGF)-beta Receptor-interacting Protein TRIP-1 Acts as a Modulator of the TGF-beta Response.

L. Choy and R. Derynck (1998)
J. Biol. Chem. 273, 31455-31462
 |  Abstract »  |  Full Text »  |  PDF »

Gestational Changes in the Levels of Transforming Growth Factor-{beta}1 (TGF{beta}1) and TGF{beta} Receptor Types I and II in the Human Myometrium.

P. Hatthachote, J. Morgan, W. Dunlop, G. N. Europe-Finner, and J. I. Gillespie (1998)
J. Clin. Endocrinol. Metab. 83, 2987-2992
 |  Abstract »  |  Full Text »

Role of Transforming Growth Factor (TGF)-{beta} Type I and TGF-{beta} Type II Receptors in the TGF-{beta}1-Regulated Gene Expression in Pituitary Prolactin-Secreting Lactotropes.

D. K. Sarkar, M. Pastorcic, A. De, M. Engel, H. Moses, and M. B. Ghasemzadeh (1998)
Endocrinology 139, 3620-3628
 |  Abstract »  |  Full Text »  |  PDF »

Osteoblastic Responses to TGF-beta during Bone Remodeling.

A. Erlebacher, E. H. Filvaroff, J.-Q. Ye, and R. Derynck (1998)
Mol. Biol. Cell 9, 1903-1918
 |  Abstract »  |  Full Text »

TGF-{beta}1 as an Endogenous Defender Against Macrophage-Triggered Stromelysin Gene Expression in the Glomerulus.

M. Kitamura (1998)
J. Immunol. 160, 5163-5168
 |  Abstract »  |  Full Text »  |  PDF »

Growth factor involvement in progression of prostate cancer.

P. J. Russell, S. Bennett, and P. Stricker (1998)
Clin. Chem. 44, 705-723
 |  Abstract »  |  Full Text »  |  PDF »

Up-regulation of Transforming Growth Factor (TGF)-beta Receptors by TGF-beta 1 in COLO-357 Cells.

J. Kleeff and M. Korc (1998)
J. Biol. Chem. 273, 7495-7500
 |  Abstract »  |  Full Text »  |  PDF »

XBMPRII, a novel Xenopus type II receptor mediating BMP signaling in embryonic tissues.

A Frisch and C. Wright (1998)
Development 125, 431-442
 |  Abstract »  |  PDF »

Inhibition of Protein Tyrosine Kinases Attenuates Increases in Expression of Transforming Growth Factor-ß Isoforms and Their Receptors Following Arterial Injury.

M. R. Ward, A. Agrotis, P. Kanellakis, R. Dilley, G. Jennings, and A. Bobik (1997)
Arterioscler Thromb Vasc Biol 17, 2461-2470
 |  Abstract »  |  Full Text »

Expression of a Truncated, Kinase-Defective TGF-{beta} Type II Receptor in Mouse Skeletal Tissue Promotes Terminal Chondrocyte Differentiation and Osteoarthritis.

R. Serra, M. Johnson, E. H. Filvaroff, J. LaBorde, D. M. Sheehan, R. Derynck, and H. L. Moses (1997)
J. Cell Biol. 139, 541-552
 |  Abstract »  |  Full Text »  |  PDF »

The Role of Transforming Growth Factor-{beta} in the Regulation of Estrogen Receptor Expression in the MCF-7 Breast Cancer Cell Line.

A. Stoica, M. Saceda, A. Fakhro, H. B. Solomon, B. D. Fenster, and M. B. Martin (1997)
Endocrinology 138, 1498-1505
 |  Abstract »  |  Full Text »  |  PDF »

Expression of a dominant-negative type II transforming growth factor beta  (TGF-beta ) receptor in the epidermis of transgenic mice blocks TGF-beta -mediated growth inhibition.

X.-J. Wang, D. A. Greenhalgh, J. R. Bickenbach, A. Jiang, D. S. Bundman, T. Krieg, R. Derynck, and D. R. Roop (1997)
PNAS 94, 2386-2391
 |  Abstract »  |  Full Text »  |  PDF »

Processing of the Transforming Growth Factor beta Type I and II Receptors. BIOSYNTHESIS AND LIGAND-INDUCED REGULATION.

K. M. Koli and C. L. Arteaga (1997)
J. Biol. Chem. 272, 6423-6427
 |  Abstract »  |  Full Text »  |  PDF »

A Xenopus type I activin receptor mediates mesodermal but not neural specification during embryogenesis.

C Chang, P. Wilson, L. Mathews, and A Hemmati-Brivanlou (1997)
Development 124, 827-837
 |  Abstract »  |  PDF »

Binding Affinity of Transforming Growth Factor-beta for Its Type II Receptor Is Determined by the C-terminal Region of the Molecule.

S. W. Qian, J. K. Burmester, M. L.-S. Tsang, J. A. Weatherbee, A. P. Hinck, D. J. Ohlsen, M. B. Sporn, and A. B. Roberts (1996)
J. Biol. Chem. 271, 30656-30662
 |  Abstract »  |  Full Text »  |  PDF »

FKBP-12 Recognition Is Dispensable For Signal Generation by Type I Transforming Growth Factor-beta Receptors.

M.-J. Charng, P. Kinnunen, J. Hawker, T. Brand, and M. D. Schneider (1996)
J. Biol. Chem. 271, 22941-22944
 |  Abstract »  |  Full Text »  |  PDF »

Chimeric Granulocyte/Macrophage Colony-stimulating Factor/Transforming Growth Factor-beta (TGF-beta ) Receptors Define a Model System for Investigating the Role of Homomeric and Heteromeric Receptors in TGF-beta Signaling.

R. A. Anders and E. B. Leof (1996)
J. Biol. Chem. 271, 21758-21766
 |  Abstract »  |  Full Text »  |  PDF »

Reduced Expression of Transforming Growth Factor beta Type I Receptor Contributes to the Malignancy of Human Colon Carcinoma Cells.

J. Wang, W. Han, E. Zborowska, J. Liang, X. Wang, J. K.V. Willson, L. Sun, and M. G. Brattain (1996)
J. Biol. Chem. 271, 17366-17371
 |  Abstract »  |  Full Text »  |  PDF »

Adenovirus-mediated Transfer of a Truncated Transforming Growth Factor-beta (TGF-beta ) Type II Receptor Completely and Specifically Abolishes Diverse Signaling by TGF-beta in Vascular Wall Cells in Primary Culture.

H. Yamamoto, H. Ueno, A. Ooshima, and A. Takeshita (1996)
J. Biol. Chem. 271, 16253-16259
 |  Abstract »  |  Full Text »  |  PDF »

Requirement of Transforming Growth Factor-beta (TGF-beta) Type II Receptor for TGF-beta-induced Proliferation and Growth Inhibition.

Y. Zhao and S. L. Young (1996)
J. Biol. Chem. 271, 2369-2372
 |  Abstract »  |  Full Text »  |  PDF »

Transforming Growth Factor-beta (TGF-beta)-induced Down-regulation of Cyclin A Expression Requires a Functional TGF-beta Receptor Complex.

X.-H. Feng, E. H. Filvaroff, and R. Derynck (1995)
J. Biol. Chem. 270, 24237-24245
 |  Abstract »  |  Full Text »  |  PDF »

Inhibition of Capillary Morphogenesis and Associated Apoptosis by Dominant Negative Mutant Transforming Growth Factor-beta Receptors.

M. E. Choi and B. J. Ballermann (1995)
J. Biol. Chem. 270, 21144-21150
 |  Abstract »  |  Full Text »  |  PDF »

Expression of Transforming Growth Factor Type III Receptor in Vascular Endothelial Cells Increases Their Responsiveness to Transforming Growth Factor [IMAGE]2.

S. Sankar, N. Mahooti-Brooks, M. Centrella, T. L. McCarthy, and J. A. Madri (1995)
J. Biol. Chem. 270, 13567-13572
 |  Abstract »  |  Full Text »  |  PDF »

Phosphorylation-dependent Interaction of the Cytoplasmic Domains of the Type I and Type II Transforming Growth Factor-[IMAGE] Receptors.

R.-H. Chen, H. L. Moses, E. M. Maruoka, R. Derynck, and M. Kawabata (1995)
J. Biol. Chem. 270, 12235-12241
 |  Abstract »  |  Full Text »  |  PDF »

Inactive Type II and Type I Receptors for TGFbeta Are Dominant Inhibitors of TGFbeta-dependent Transcription.

T. Brand and M. D. Schneider (1995)
J. Biol. Chem. 270, 8274-8284
 |  Abstract »  |  Full Text »  |  PDF »

Transforming Growth Factor beta Activation of p44[IMAGE] in Proliferating Cultures of Epithelial Cells.

M. T. Hartsough and K. M. Mulder (1995)
J. Biol. Chem. 270, 7117-7124
 |  Abstract »  |  Full Text »  |  PDF »

Signaling Activity of Homologous and Heterologous Transforming Growth Factor-beta Receptor Kinase Complexes.

D. Vivien, L. Attisano, and J. Massagué (1995)
J. Biol. Chem. 270, 7134-7141
 |  Abstract »  |  Full Text »  |  PDF »

GH3 Pituitary Tumor Cells Contain Heteromeric Type I and Type II Receptor Complexes for Transforming Growth Factor beta and Activin-A.

A. Moustakas, T. Takumi, H. Y. Lin, and H. F. Lodish (1995)
J. Biol. Chem. 270, 765-769
 |  Abstract »  |  Full Text »  |  PDF »

pRb is necessary for inhibition of N-myc expression by TGF-beta 1 in embryonic lung organ cultures.

R Serra and H. Moses (1995)
Development 121, 3057-3066
 |  Abstract »  |  PDF »

Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring.

M Shah, D. Foreman, and M. Ferguson (1995)
J. Cell Sci. 108, 985-1002
 |  Abstract »  |  PDF »

Collagen matrices attenuate the collagen-synthetic response of cultured fibroblasts to TGF-beta.

R. Clark, L. Nielsen, M. Welch, and J. McPherson (1995)
J. Cell Sci. 108, 1251-1261
 |  Abstract »  |  PDF »

Specific interaction of type I receptors of the TGF-beta family with the immunophilin FKBP-12.

T Wang, P. Donahoe, and A. Zervos (1994)
Science 265, 674-676
 |  Abstract »  |  PDF »

Inhibition of myogenic differentiation in myoblasts expressing a truncated type II TGF-beta receptor.

E. Filvaroff, R Ebner, and R Derynck (1994)
Development 120, 1085-1095
 |  Abstract »  |  PDF »

Induction of human tenascin (neuronectin) by growth factors and cytokines: cell type-specific signals and signalling pathways.

W. Rettig, H. Erickson, A. Albino, and P Garin-Chesa (1994)
J. Cell Sci. 107, 487-497
 |  Abstract »  |  PDF »

The murine type II TGF-beta receptor has a coincident embryonic expression and binding preference for TGF-beta 1.

S Lawler, A. Candia, R Ebner, L Shum, A. Lopez, H. Moses, C. Wright, and R Derynck (1994)
Development 120, 165-175
 |  Abstract »  |  PDF »

A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the mullerian duct.

W. Baarends, M. van Helmond, M Post, P. van der Schoot, J. Hoogerbrugge, J. de Winter, J. Uilenbroek, B Karels, L. Wilming, J. Meijers, et al. (1994)
Development 120, 189-197
 |  Abstract »  |  PDF »

Determination of type I receptor specificity by the type II receptors for TGF-beta or activin.

R Ebner, R. Chen, S Lawler, T Zioncheck, and R Derynck (1993)
Science 262, 900-902
 |  Abstract »  |  PDF »

Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor.

R Ebner, R. Chen, L Shum, S Lawler, T. Zioncheck, A Lee, A. Lopez, and R Derynck (1993)
Science 260, 1344-1348
 |  Abstract »  |  PDF »

Transforming Growth Factor-beta 1-induced Activation of the ERK Pathway/Activator Protein-1 in Human Lung Fibroblasts Requires the Autocrine Induction of Basic Fibroblast Growth Factor.

G. A. Finlay, V. J. Thannickal, B. L. Fanburg, and K. E. Paulson (2000)
J. Biol. Chem. 275, 27650-27656
 |  Abstract »  |  Full Text »  |  PDF »

Smad7-dependent Regulation of Heme Oxygenase-1 by Transforming Growth Factor-beta in Human Renal Epithelial Cells.

N. Hill-Kapturczak, L. Truong, V. Thamilselvan, G. A. Visner, H. S. Nick, and A. Agarwal (2000)
J. Biol. Chem. 275, 40904-40909
 |  Abstract »  |  Full Text »  |  PDF »

Functional Roles for the Cytoplasmic Domain of the Type III Transforming Growth Factor beta Receptor in Regulating Transforming Growth Factor beta Signaling.

G. C. Blobe, W. P. Schiemann, M.-C. Pepin, M. Beauchemin, A. Moustakas, H. F. Lodish, and M. D. O'Connor-McCourt (2001)
J. Biol. Chem. 276, 24627-24637
 |  Abstract »  |  Full Text »  |  PDF »

Rapid and dynamic regulation of TGF-beta receptors on blood vessels and fibroblasts during ischemia-reperfusion injury.

R. Mortazavi-Haghighat, K. Taghipour-Khiabani, S. David, C. L. Kerrigan, and A. Philip (2002)
Am J Physiol Cell Physiol 282, C1161-C1169
 |  Abstract »  |  Full Text »  |  PDF »

To Advertise   |   Find Products